MICROA BIOACTIVES AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: ET
Enrique Tabares Rodriguez1973
Chairman of the board: RH
Rune Haddeland1968
Years since formation: 2 years; since Feb 1, 2022
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 30,000; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Annual total result 2023: -25,523; NOK
Total equity 2023: -1,093; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
ET Enrique Tabares Rodriguez 1973	Managing Director/CEO	-

Board

Name	Role	Shares
RH Rune Haddeland 1968	Chairman	-

Others

Name	Role	Shares
E ERGA REVISJON AS	Auditor	-
V VIEW LEDGER AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
GL Gunvor Lillian Dahle 1949	-	12.08 % indirectly
PØ Per Øyvind Berge 1966	-	8.72 % indirectly
SD Svein Dahle 1951	-	8.47 % indirectly
BD Bjørn Dahle 1947	-	7.75 % indirectly
AS Alfred Skartveit 1971	-	6.39 % indirectly
OS Olav Skartveit 1969	-	6.39 % indirectly
TS Thore Skartveit 1978	-	6.39 % indirectly
LA Lars Andreas Dahle 1979	-	4.22 % indirectly
BA Bjørn Anders Dahle 1974	-	3.88 % indirectly
AD Annette Dahle 1978	-	3.88 % indirectly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
M MICROA AS	Ordinary shares	30,000	100 %

Last update: May 24, 2024

Group structure

MICROA AS
Total operating income 2023: NOK 4,179,962
Operating profit 2023: NOK -4,464,262
Employees: 0

Financials

in NOK

Summary

Year	2023	2022
Total operating income	0	0
Annual Total Result	-25,523	0
Total assets	33,049	24,430
Total liabilities	34,142	0
Total equity	-1,093	24,430

P&L

Year	2023	2022
Total operating income	0	0
Total operating costs	25,523	0
Operating result	-25,523	0
Financial income/costs	0	0
Profit before tax	-25,523	0
Total tax & extraordinary income/cost	0	0
Annual Total Result	-25,523	0

Balance overview

Year	2023	2022
Total fixed assets	0	0
Total current assets	33,049	24,430
Total assets	33,049	24,430
Short term debt	34,142	0
Long term debt	0	0
Total liabilities	34,142	0
Contributed capital	24,430	24,430
Retained earnings	-25,523	0
Total equity	-1,093	24,430
Total equity and liabilities	33,049	24,430

MICROA BIOACTIVES AS928 651 460